Norton Children’s Services

At Norton Children’s we recognize the importance of our referring providers and value our ongoing relationships. As a health care professional, if you have a question or need assistance, contact one of our provider liaisons or call Norton Children’s Direct Connect.

Norton Children’s Direct Connect

Your direct line to Norton Children’s specialty services

Norton Children’s Direct Connect is designed to allow you to speak with a Norton Children’s specialty provider in real time, when you need it most. The line is answered by nurses who can directly connect you with a provider to discuss a case, seek advice and determine next steps for care — anytime, day or night.

  • Providers can use Direct Connect to speak with a Norton Children’s specialty provider for direction on a patient.
  • Providers can speak with a physician about a patient admission.
  • Providers or office staff can schedule a patient with a Norton Children’s specialty provider.
  • Providers or office staff can schedule a patient for a diagnostic test.

Thank you for entrusting your patients’ care to the physicians and staff of Norton Children’s. We are always looking for ways to improve service to our referring providers and welcome your suggestions on how we can improve our service to you and your patients.

Recent News
Lisal J. Folsom, M.D., is shown discussing Tzield with a colleague.

Tzield may delay Stage 3 Type 1 diabetes in adults and children

Recently approved Tzield (teplizumab-mzwv), is delivering breakthrough results that suggest it may delay the onset of Stage 3 Type 1 diabetes by an average of two years. The first-in-class drug is approved for adults and […]

Kupper A. Wintergerst, M.D., is the local principal investigator in a Phase 3 clinical trial of Afrezza inhaled insulin for pediatric diabetes patients.

Ultra-fast-acting inhaled insulin, Afrezza, trialed at Norton Children’s Endocrinology

Afrezza inhaled insulin, currently approved for adults, is being tested for children in a clinical trial at Wendy Novak Diabetes Institute, a part of Norton Children’s Endocrinology, affiliated with the UofL School of Medicine. Norton […]

Michael Angelo C. Huang, M.D., the study chair for the DFMO medulloblastoma clinical trial, is shown

DFMO medulloblastoma clinical trial examines drug’s effectiveness for high-risk cases

Researchers are recruiting pediatric medulloblastoma patients for a novel use of difluoromethylornithine (DFMO) to prevent relapse. The multisite study, sponsored by the Beat Childhood Cancer Consortium and led by Michael Angelo C. Huang, M.D., pediatric [...]

Bahaaldin Alsoufi, M.D., discusses choosing Norwood procedure or COMPSII after palliation with a colleague.

Norwood vs. COMPSII for critical left heart obstruction with prior palliation

Surgeons face two choices for infants with critical left heart obstruction who have had prior hybrid palliation: a Norwood operation or a comprehensive stage II (COMPSII). The critical left heart obstruction cohort of the multi-institutional […]

Lisal J. Folsom, M.D., M.S., discusses misunderstandings about thyroid weight gain with a colleague.

Thyroid weight gain myths and surprises

Patients often suspect a thyroid condition is responsible for their weight gain or their weight loss struggles. Much of the stimulus for this belief is based on the internet, according to Lisal J. Folsom, M.D., […]

Intraoperative electrophysiology mapping allows surgeon to steer clear of invisible conduction tissue

The patient A 4-year-old girl presented with congenital heart disease consisting of partial atrioventricular canal defect. Surgical repair was necessary. The challenge Injury to the cardiac conduction system during cardiac surgery may result in complete heart […]

August 2023 Norton Children’s Medical Group New Providers

Rebecca M. Callahan, D.O. ­ Pediatric Hospital Medicine Logan M. Eberly, M.D. Pediatric Cardiology Dominique C. Elmore, D.O. ­ Pediatric Emergency Medicine Allison N. Lyle, M.D. ­ Neonatology Aaron J. Samide, M.D. Pediatric Hospital Medicine […]

July 2023 Norton Children’s Medical Group New Providers

Laura L. Voegele, M.D. ­ Pediatrics Sarah L. Simpson, APRN­ Neonatology ASara B Cochran, APRN ­ Pediatric Urology Soraya A Morris, APRN ­ Pediatric Emergency Medicine Andrew Thomas, LMFT Pediatric Endocrinology

Pictured is a high-risk pregnancy patient who would benefit from the collaborative care at Norton Children’s.

Norton Children’s collaborates with patients’ providers for high-risk pregnancy care

If a congenital heart condition is expected for a high-risk pregnancy, referring providers still can  retain their patients through delivery by collaborating with Norton Children and Norton Healthcare. We use an integrated approach for collaborative […]

Get Our Monthly Newsletter

Stay informed on the latest offerings and treatments available at Norton Healthcare by subscribing to our monthly enewsletter.

Subscribe

Make a Referral

Partnering with you in caring for your patients.

Refer a Patient
Are You a Patient?
Provider Spotlight

Keith A. McLean, M.D.

Norton Heart & Vascular Institute welcomes Keith A. McLean, M.D., cardiologist; office hours dedicated to residents of Madison and surrounding communities.

Read More

Shawn W. Adams, M.D., joins Norton Leatherman Spine

After completing a pair of spinal fellowships in the latest surgical techniques and technologies, Shawn W. Adams, M.D., has joined Norton Leatherman Spine and Norton Neuroscience Institute. Dr. Adams’ fellowships covered complex adult spine, deformity [...]

Read Full Story

Tzield may delay Stage 3 Type 1 diabetes in adults and children

Recently approved Tzield (teplizumab-mzwv), is delivering breakthrough results that suggest it may delay the onset of Stage 3 Type 1 diabetes by an average of two years. The first-in-class drug is approved for adults and […]

Read Full Story

Ultra-fast-acting inhaled insulin, Afrezza, trialed at Norton Children’s Endocrinology

Afrezza inhaled insulin, currently approved for adults, is being tested for children in a clinical trial at Wendy Novak Diabetes Institute, a part of Norton Children’s Endocrinology, affiliated with the UofL School of Medicine. Norton […]

Read Full Story

DFMO medulloblastoma clinical trial examines drug’s effectiveness for high-risk cases

Researchers are recruiting pediatric medulloblastoma patients for a novel use of difluoromethylornithine (DFMO) to prevent relapse. The multisite study, sponsored by the Beat Childhood Cancer Consortium and led by Michael Angelo C. Huang, M.D., pediatric [...]

Read Full Story

Butyrate-producing gut bacteria a promising avenue for Alzheimer’s treatment

Butyrate-producing gut bacteria are a promising target for preventing and treating memory loss associated with Alzheimer’s disease, according to research presented recently at the Alzheimer’s Association International Conference (AAIC) in Amsterdam, Netherlands. The research in […]

Read Full Story

Search our entire site.